Genomics and Digital Medical Devices Lead Health Technology Funding

We’ve previously found that health technology funding is on an overall upward trend. Now we are taking a closer look on our health technology research platform to compare funding by category. Our analysis reveals two observations:

  • The Genomics category leads the sector in Q2 funding
  • The Digital Medical Devices category leads the sector in all-time funding

We’ll highlight these observations with some graphics and discussions below.

The Genomics Category Leads Health Technology In Q2 Funding

To start off, let’s review the amount of funding raised this quarter by each category within health technology.

Health Technology Latest Quarter Category Funding
Health Technology Latest Quarter Category Funding

The above graphic highlights that the Genomics category leads the sector in Q2 funding with just under $1B. Its funding is 1.4 times the funding of the next category, Digital Medical Devices at $700M.

Genomics companies utilize human genome data for analytics, prevention, and treatment. Some example companies in this category are 23andMe, Helix, and Counsyl.

Let’s now investigate how these categories’ funding compare with each other historically.

The Digital Medical Devices Category Leads the Sector in All-Time Funding

The graph below shows the all-time funding for different health technology categories. The Q2 funding and growth rates of these categories are also highlighted.

Health Technology Total Category Funding
Health Technology Total Category Funding

As the bar graph indicates, the Digital Medical Devices category leads the sector in total funding at almost $14B. The Genomics category follows in a close second place with an all-time funding of $13.6B. These two categories’ funding are more than twice the funding of the next category, IoT Fitness at $6.6B.

Digital Medical Device companies build IT-enabled medical and diagnostic devices for doctors. These devices include detection equipment, monitoring equipment, and surgical tools. Some example companies are Signostics, MediBeacon, Stimwave, and AliveCor.

In summary, it’s clear that the Genomics and Digital Medical Devices categories are leading the sector in funding. Let’s see how the the rest of 2018 shapes up for health technology!

To learn more about our complete health technology report and research platform, visit us at www.venturescanner.com or contact us at info@venturescanner.com.

Health Technology Startup Highlights  – Q2 2018

Here is our Q2 2018 summary report on the health technology startup sector. The following report includes a sector overview and recent activity.

To learn more about our complete health technology report and research platform, visit us at www.venturescanner.com or contact info@venturescanner.com.

Health Technology Sector Starts Maturing

As we previously noted, health technology funding is experiencing robust growth. We’ve now gone one level deeper in our analysis on our Health Technology Report and Research Platform and determined that the health technology sector is starting to mature.

This conclusion comes from two key observations:

  • Funding amount percentages showed a slight shift to later stages
  • Funding count percentages showed a clear shift to later stages

We’ll explain these key observations with some graphics and discussions below.

To help set the stage, the graphic below highlights health technology funding amounts over time. As you can see, the sector’s overall funding demonstrated consistent growth.

Health Technology Funding by Quarter
Health Technology Funding by Quarter

Health Technology Funding Amount Percentages Shifting Slightly to Later Stages

Let’s examine the health technology funding amounts by round as a percentage of the total funding amount by year.

Health Technology Funding Amount Percentages
Health Technology Funding Amount Percentages

The above graph indicates that there has been a slight shift to later-stage funding. In 2012, Seed and Series A funding amounts accounted for around 25% of total funding. By 2017, that total had dropped to under 20%. Consequently, the funding amounts from Series B onward grew from around 75% of total funding to over 80%.

Would the funding count percentages confirm this trend? Let’s examine in the the next section to find out.

Health Technology Funding Count Percentages Clearly Shifting to Later-Stage Events

The below graph shows the health technology funding event counts by round as a percentage of total events.

Health Technology Funding Count Percentages
Health Technology Funding Count Percentages

This graph paints a clearer picture of the funding shift than the previous funding amount graph. In particular, Seed funding count percentage decreased by more than half its size from 53% to 23%. The funding count percentages in all other rounds increased by various magnitudes from 2012 to 2017.

Conclusion: Health Technology Sector Matures As Funding Shifts to Later Stages

In summary, we have seen health technology funding amounts and funding event counts shift from the early-stage rounds to mid and late-stage rounds. These observations led us to conclude that the health technology sector is starting to mature.

To learn more about our complete health technology report and research platform, visit us at www.venturescanner.com or contact us at info@venturescanner.com.